197 related articles for article (PubMed ID: 38509359)
1. A distinct Fusobacterium nucleatum clade dominates the colorectal cancer niche.
Zepeda-Rivera M; Minot SS; Bouzek H; Wu H; Blanco-Míguez A; Manghi P; Jones DS; LaCourse KD; Wu Y; McMahon EF; Park SN; Lim YK; Kempchinsky AG; Willis AD; Cotton SL; Yost SC; Sicinska E; Kook JK; Dewhirst FE; Segata N; Bullman S; Johnston CD
Nature; 2024 Apr; 628(8007):424-432. PubMed ID: 38509359
[TBL] [Abstract][Full Text] [Related]
2. Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome.
Flanagan L; Schmid J; Ebert M; Soucek P; Kunicka T; Liska V; Bruha J; Neary P; Dezeeuw N; Tommasino M; Jenab M; Prehn JH; Hughes DJ
Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1381-90. PubMed ID: 24599709
[TBL] [Abstract][Full Text] [Related]
3. Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum.
Brennan CA; Nakatsu G; Gallini Comeau CA; Drew DA; Glickman JN; Schoen RE; Chan AT; Garrett WS
mBio; 2021 Apr; 12(2):. PubMed ID: 33824205
[TBL] [Abstract][Full Text] [Related]
4. Highly sensitive stool DNA testing of Fusobacterium nucleatum as a marker for detection of colorectal tumours in a Japanese population.
Suehiro Y; Sakai K; Nishioka M; Hashimoto S; Takami T; Higaki S; Shindo Y; Hazama S; Oka M; Nagano H; Sakaida I; Yamasaki T
Ann Clin Biochem; 2017 Jan; 54(1):86-91. PubMed ID: 27126270
[TBL] [Abstract][Full Text] [Related]
5. Comparative Analysis of Colon Cancer-Derived Fusobacterium nucleatum Subspecies: Inflammation and Colon Tumorigenesis in Murine Models.
Queen J; Domingue JC; White JR; Stevens C; Udayasuryan B; Nguyen TTD; Wu S; Ding H; Fan H; McMann M; Corona A; Larman TC; Verbridge SS; Housseau F; Slade DJ; Drewes JL; Sears CL
mBio; 2021 Feb; 13(1):e0299121. PubMed ID: 35130731
[TBL] [Abstract][Full Text] [Related]
6. Relationship between
Proença MA; Biselli JM; Succi M; Severino FE; Berardinelli GN; Caetano A; Reis RM; Hughes DJ; Silva AE
World J Gastroenterol; 2018 Dec; 24(47):5351-5365. PubMed ID: 30598580
[TBL] [Abstract][Full Text] [Related]
7. Analysis of
Guven DC; Dizdar O; Alp A; Akdoğan Kittana FN; Karakoc D; Hamaloglu E; Lacin S; Karakas Y; Kilickap S; Hayran M; Yalcin S
Biomark Med; 2019 Jun; 13(9):725-735. PubMed ID: 31157977
[No Abstract] [Full Text] [Related]
8. [Relationships between the enrichment of ETBF, Fn, Hp in intestinal and colorectal cancer].
Zhang J; Lu XL; Zhao G; Shi HT; Geng Y; Zhong WT; Dong L
Zhonghua Zhong Liu Za Zhi; 2018 Feb; 40(2):99-104. PubMed ID: 29502368
[No Abstract] [Full Text] [Related]
9. Enrichment of Prevotella intermedia in human colorectal cancer and its additive effects with Fusobacterium nucleatum on the malignant transformation of colorectal adenomas.
Lo CH; Wu DC; Jao SW; Wu CC; Lin CY; Chuang CH; Lin YB; Chen CH; Chen YT; Chen JH; Hsiao KH; Chen YJ; Chen YT; Wang JY; Li LH
J Biomed Sci; 2022 Oct; 29(1):88. PubMed ID: 36303164
[TBL] [Abstract][Full Text] [Related]
10. A Simple and Novel Fecal Biomarker for Colorectal Cancer: Ratio of
Guo S; Li L; Xu B; Li M; Zeng Q; Xiao H; Xue Y; Wu Y; Wang Y; Liu W; Zhang G
Clin Chem; 2018 Sep; 64(9):1327-1337. PubMed ID: 29914865
[TBL] [Abstract][Full Text] [Related]
11. A newly developed PCR-based method revealed distinct Fusobacterium nucleatum subspecies infection patterns in colorectal cancer.
Bi D; Zhu Y; Gao Y; Li H; Zhu X; Wei R; Xie R; Wei Q; Qin H
Microb Biotechnol; 2021 Sep; 14(5):2176-2186. PubMed ID: 34309194
[TBL] [Abstract][Full Text] [Related]
12.
Chen S; Su T; Zhang Y; Lee A; He J; Ge Q; Wang L; Si J; Zhuo W; Wang L
Gut Microbes; 2020 May; 11(3):511-525. PubMed ID: 31910722
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneous distribution of Fusobacterium nucleatum in the progression of colorectal cancer.
Yamamoto S; Kinugasa H; Hirai M; Terasawa H; Yasutomi E; Oka S; Ohmori M; Yamasaki Y; Inokuchi T; Harada K; Hiraoka S; Nouso K; Tanaka T; Teraishi F; Fujiwara T; Okada H
J Gastroenterol Hepatol; 2021 Jul; 36(7):1869-1876. PubMed ID: 33242360
[TBL] [Abstract][Full Text] [Related]
14. Fusobacterium nucleatum-triggered neutrophil extracellular traps facilitate colorectal carcinoma progression.
Kong X; Zhang Y; Xiang L; You Y; Duan Y; Zhao Y; Li S; Wu R; Zhang J; Zhou L; Duan L
J Exp Clin Cancer Res; 2023 Sep; 42(1):236. PubMed ID: 37684625
[TBL] [Abstract][Full Text] [Related]
15. Fusobacterium nucleatum and colorectal cancer: A mechanistic overview.
Hashemi Goradel N; Heidarzadeh S; Jahangiri S; Farhood B; Mortezaee K; Khanlarkhani N; Negahdari B
J Cell Physiol; 2019 Mar; 234(3):2337-2344. PubMed ID: 30191984
[TBL] [Abstract][Full Text] [Related]
16. Association of Fusobacterium nucleatum infection with colorectal cancer in Chinese patients.
Li YY; Ge QX; Cao J; Zhou YJ; Du YL; Shen B; Wan YJ; Nie YQ
World J Gastroenterol; 2016 Mar; 22(11):3227-33. PubMed ID: 27004000
[TBL] [Abstract][Full Text] [Related]
17. The Role of Fecal
Liu K; Yang X; Zeng M; Yuan Y; Sun J; He P; Sun J; Xie Q; Chang X; Zhang S; Chen X; Cai L; Xie Y; Jiao X
Dis Markers; 2021; 2021():1171239. PubMed ID: 34853619
[TBL] [Abstract][Full Text] [Related]
18.
Xu C; Fan L; Lin Y; Shen W; Qi Y; Zhang Y; Chen Z; Wang L; Long Y; Hou T; Si J; Chen S
Gut Microbes; 2021; 13(1):1980347. PubMed ID: 34632963
[TBL] [Abstract][Full Text] [Related]
19. Association of Fusobacterium nucleatum infection with the clinicopathological characteristics in colorectal cancer patients.
Pang SW; Armon S; Chook JB; Chew J; Peh KB; Lim WW; Peh SC; Teow SY
Mol Biol Rep; 2024 Jan; 51(1):124. PubMed ID: 38227097
[TBL] [Abstract][Full Text] [Related]
20. [Advances on the treatment of
Wang H; Hou X; Liu J; Yang C
Sheng Wu Gong Cheng Xue Bao; 2023 Sep; 39(9):3670-3680. PubMed ID: 37805845
[No Abstract] [Full Text] [Related]
[Next] [New Search]
